Participation in prenatal screening tests and intentions concerning selective termination in Finnish maternity care

Fetal Diagnosis and Therapy

Volumn 14, Issue 2, 1999, Pages 71-79

  Santalahti, Päivi ^a   Hemminki, Elina ^b   Aro, Arja R ^b   Helenius, Hans ^b   Ryynänen, Markku ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Informed consent; Intention; Participation; Prenatal screening; Selective termination

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; DISABLED PERSON; EPIDEMIOLOGY; FEMALE; FETUS ECHOGRAPHY; FETUS MALFORMATION; FINLAND; HEALTH CARE DELIVERY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MATERNAL CARE; MEDICAL DECISION MAKING; OBSTETRICS; PATIENT COMPLIANCE; PATIENT INFORMATION; PREGNANCY TERMINATION; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE;

CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; FINLAND; GENETICS AND REPRODUCTION; PREGNANT WOMEN; SELECTIVE ABORTION; SOCIAL INTERACTION; SURVEY;

ABORTION, INDUCED; ADULT; DECISION MAKING; DISCLOSURE; FEMALE; FETAL DISEASES; FINLAND; HUMANS; PREGNANCY; PREGNANT WOMEN; PRENATAL DIAGNOSIS; QUESTIONNAIRES; ULTRASONOGRAPHY, PRENATAL;

EID: 0033009059     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020893     Document Type: Article

References (48)

1. Marteau TM: Towards informed decisions about prenatal testing: A review. Prenat Diagn 1995;15:1215-1226.
2. Marteau TM, Slack J, Kidd J, Shaw RW: Presenting a routine screening test in antenatal care: Practice observed. Public Health 1992; 106:131-141.
3. Marteau TM, Plenicar M, Kidd J: Obstetricians presenting amniocentesis to pregnant women: Practice observed. J Reprod Infant Psychol 1993;11:3-10.
4. Press NA, Browner CH: 'Collective fictions': Similarities in reasons for accepting maternal serum alpha-fetoprotein screening among women of diverse ethnic and social backgrounds. Fetal Diagn Ther 1993;8(suppl 1):97-106.
5. Santalahti P, Hemminki E: Use of prenatal screening tests in Finland. Eur J Public Health 1998;8:8-14.
6. Santalahti P, Aro AR, Hemminki E, Helenius H, Ryynänen M: On what grounds do women participate in prenatal screening? Prenat Diagn 1998;18:153-165.
7. Agresti A: Categorical Data Analysis. New York, Wiley, 1990.
8. Dixon WJ, Brown MB, Engelman L, Jennrich RI: BMDP Statistical Software Manual I-II. Berkeley, University of California Press, 1990.
9. CSS: Statistica Vol I-III, Quick CSS. Tulsa Oklahoma, Stat Soft Inc, 1986-1991.
10. Hämäläinen H, Rasimus A, Ritamo M: Abortions 1993. Helsinki, National Research and Development Centre for Welfare and Health, 1995.
11. Crang-Svalenius E, Dykes AK, Jorgensen C: Women's informed choice of prenatal diagnosis: Early ultrasound examination - routine ultrasound examination - age-independent amniocentesis. Fetal Diagn Ther 1996;11:20-25.
12. Porter M, Macintyre S: What is, must be best: A research note on conservative or deferential responses to antenatal care provision. Soc Sci Med 1984;11:1197-1200.
13. Salonen R, Kurki L, Lappalainen M: Experiences of mothers participating in maternal serum screening for Down's syndrome. Eur J Hum Genet 1986;4:113-119.
14. Hemminki E, Sihvo S: Knowledge of prenatal care among non-pregnant women: An explanation for early attendance. Scand J Soc Med 1996;24:152-154.
15. Gissler M, Rasimus A, Ritvanen A, Toukomaa H: Reproduction and its trends - Statistics on pregnancies, childbirths, sterilizations and congenital malformations in Finland. Helsinki, National Research and Development Centre for Welfare and Health, 1996.
16. Saxton M: Prenatal screening and discriminatory attitudes about disability. Women Health 1987;13:217-235.
17. Elkins TE, Stovall TG, Wilroy S, Dacus JV: Attitudes of mothers of children with Down's syndrome concerning amniocentesis, abortion, and prenatal genetic counselling techniques. Obstet Gynecol 1986;68:181-184.
18. Itälinna M, Leinonen E, Saloviita T: Kehitysvammaisen lapsen perheen voimavarat ja selvityminen. (The families with mentally retarded children, resources and managing.) Tampere, Kehitysvammaisten tukiliitto ry, 1994.
19. Marteau TM, Drake H, Bobrow M: Counselling following diagnosis of a fetal abnormality: The differing approaches of obstetricians, clinical geneticists and genetic nurses. J Med Genet 1994;31:864-867.
20. Sanden ML, Bjurulf P: Pregnant women's attitudes for accepting or declining a serum-alpha-fetoprotein test. Scand J Soc Med 1988;16: 265-271.
21. Berne-Formell K, Josefson G, Kjessler B: Who declines from antenatal serum alpha-fetoprotein screening - and why? Acta Obstet Gynecol Scand 1984;63:687-691.
22. Marteau TM, Johnston M, Shaw RW, Slack J: Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down's syndrome. Br J Obstet Gynaecol 1989;96:739-748.
23. Marteau TM, Kidd J, Cook R, Michie S, Johnston M, Slack J, Shaw RW: Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstet Gynaecol 1991;98:282-286.
24. Kyle D, Cummins C, Evans S: Factors affecting the uptake of screening for neural tube defect. Br J Obstet Gynaecol 1988;95:560-564.
25. Scholz C, Endres M, Murken J: Decision for or against the utilization of amniocentesis and chorion villus biopsy. J Psychosom Obstet Gynecol 1990;11(special issue 1):27-40.
26. Davies BL, Doran TA: Factors in a woman's decision to undergo genetic amniocentesis for advanced maternal age. Nurs Res 1982;31:56-59.
27. Sjögren B, Uddenberg N: Decision-making during the prenatal diagnostic procedure. A questionnaire and interview study of 211 women participating in prenatal diagnosis. Prenat Diagn 1988;8:263-273.
28. French BN, Kurczynski TW, Weaver TM, Pituch MJ: Evaluation of the Health Belief Model and decision-making regarding amniocentesis in women of advanced maternal age. Health Educ Q 1992;19:177-186.
29. Marriot S, Pelz J, Kunze J: Why do women not utilize prenatal diagnosis? J Psychosom Obstet Gynecol 1990;11(special issue 1):41-51.
30. Thornton JG, Lilford RJ: Prenatal diagnosis of Down's syndrome. A method for measuring the consistency of women's decisions. Med Decis Making 1990;10:288-293.
31. Jorgensen FS: Declining and alpha-fetoprotein test in pregnancy why and who? Acta Obstet Gynecol Scand 1995;74:3-11.
32. Faden RR, Chwalow AJ, Orel-Crosby E, Holtzman NA, Chase GA, Leonard CO: What participants understand about a maternal serum alpha-fetoprotein screening program? Am J Public Health 1985;75:1381-1384.
33. Goel V, Glazier R, Holzapfel S, Pugh P, Summers A: Evaluation of patients' knowledge of maternal serum screening. Prenat Diagn 1996; 1:425-430.
34. Green JM, Statham H, Snowdon C: Women's knowledge of prenatal screening tests. 1. Relationships with hospital screening policy and demographic factors. J Reprod Infant Psychol 1993;11:11-20.
35. Marteau TM, Johnston M, Plenciar M, Shaw RW, Slack J: Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res 1988;32:403-408.
36. Thornton JG, Hewison J, Lilford RJ, Vail A: A randomised trial of three methods of giving information about prenatal testing. BMJ 1995;311:1127-1130.
37. Madlon-Kay DJ, Reif C, Mersy DJ, Luxenberg MG: Maternal serum alpha-fetoprotein testing: Physician experience and attitudes and their influence on patient acceptance. J Fam Pract 1992;35:395-400.
38. Marteau TM, Johnston M: Health professionals: A source of variance in health outcomes. Psychol Health 1990;5:47-58.
39. Press N, Browner CH: Why women say yes to prenatal diagnosis? Soc Sci Med 1997;45:979-989.
40. McKinlay JB: From 'promising report' to 'standard procedure': Seven stages in the career of a medical innovation. Health Soc 1981;59:374-411.
41. Hemminki E, Santalahti P, Toiviainen H: Impact of prenatal screening on maternity services - Finnish physicians' opinions. Acta Obstet Gynecol Scand 1999, in press.
42. Lorenz RP, Botti JJ, Scmidt CM, Ladda RL: Encouraging patients to undergo prenatal genetic counselling before the day of amniocentesis. J Reprod Med 1985;30:933-935.
43. Bekker H, Model M, Dennis G, Silver A, Matthew C, Bobrow M, Marteau T: Uptake of cystic fibrosis testing in primary care: Supply push or demand pull. BMJ 1993;306:1584-1586.
44. Tambor ES, Bernhardt BA, Chase GA, Faden R, Geller G, Hofman KJ, Holtzman NA: Offering cystic fibrosis carrier screening to an HMO population. Factors associated with utilization. Am J Hum Genet 1994;55:626-637.
45. Marteau TM, Johnston M, Kidd J, Michie S, Cook R: Psychological models in predicting uptake of prenatal screening. Psychol Health 1992;6:13-22.
46. Aro AR, Hakonen A, Hietala M, Lönnqvist J, Niemelä P, Peltonen L, Aula P: Acceptance of genetic testing in a general population: Age, education and gender differences. Patient Educ Couns 1997;32:41-49.
47. Santalahti P, Hemminki E, Latikka MA, Ryynänen M: Women's decision-making in prenatal screening. Soc Sci Med 1998;46:1067-1076.
48. Green JM, Statham H, Snowdon C: Screening for fetal abnormalities: Attitudes and experiences; in Chard T, Richards MPM (eds): Obstetrics in the 1990s: Current Controversies. London, MacKeith Press, 1992.